Oxygenta Pharmaceutical LimitedBSE: OXYGENTAPH

Oxygenta Pharmaceutical Limited Press Release Dec 27 2024

· Issued by Oxygenta Pharmaceutical Limited via BSE India

Filed with BSE ·

Intimation of Closure of Trading window from 1st January 2025 till 48 hours from declaration of unaudited results for the quarter ending 31st December 2024

View Attachment

6ix hasn’t read this filing yet.

Oxygenta Pharmaceutical Limited on 6ix

Story so far

Earlier from Oxygenta Pharmaceutical

Later from Oxygenta Pharmaceutical

All Oxygenta Pharmaceutical news releases